{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:58:40Z","timestamp":1790798320080,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Scha 979\/5-1"],"award-info":[{"award-number":["Scha 979\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Else Kroener Fresenius Stiftung","award":["2012_A119"],"award-info":[{"award-number":["2012_A119"]}]}],"content-domain":{"domain":["jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jdermsci.2014.09.002","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T18:54:55Z","timestamp":1411930495000},"page":"173-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: Possible implications for rosacea"],"prefix":"10.1016","volume":"76","author":[{"given":"Suzanna","family":"Salzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Kresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Koglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reinholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2014.09.002_bib0005","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09546630701485233","article-title":"The enigma of rosacea","volume":"18","author":"Marks","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice","volume":"352","author":"Powell","year":"2005","journal-title":"Rosacea. N Engl J Med"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea\u2014global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"327","key":"10.1016\/j.jdermsci.2014.09.002_bib0025","first-page":"41","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaad.2013.05.019","article-title":"Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel","volume":"69","author":"Coda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0040","doi-asserted-by":"crossref","first-page":"e16658","DOI":"10.1371\/journal.pone.0016658","article-title":"Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity","volume":"15","author":"Yamasaki","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0055","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0060","first-page":"1","article-title":"Rosacea: update on management and emerging therapies","volume":"17","author":"Fallen","year":"2012","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1189\/jlb.0403147","article-title":"Cathelicidins, multifunctional peptides of the innate immunity","volume":"75","author":"Zanetti","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0075","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0080","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0085","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.peptides.2011.06.005","article-title":"Wound healing activity of the human antimicrobial peptide LL37","volume":"32","author":"Ramos","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.2010.360","article-title":"The coordinated response of the physical and antimicrobial peptide barriers of the skin","volume":"131","author":"Borkowski","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0105","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00018-010-0567-4","article-title":"Inflammasomes: current understanding and open questions","volume":"68","author":"Bauernfeind","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0115","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/0008-5472.CAN-03-0407","article-title":"Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells","volume":"64","author":"Fan","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/jcbfm.2009.17","article-title":"Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro","volume":"29","author":"Rosell","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0130","doi-asserted-by":"crossref","first-page":"82ra38","DOI":"10.1126\/scitranslmed.3002001","article-title":"Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions","volume":"3","author":"Dombrowski","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0135","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.cub.2007.05.074","article-title":"The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes","volume":"17","author":"Feldmeyer","year":"2007","journal-title":"Curr Biol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0140","doi-asserted-by":"crossref","first-page":"12762","DOI":"10.1074\/jbc.M806084200","article-title":"NLRP3\/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury","volume":"284","author":"Yamasaki","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0145","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.4049\/jimmunol.172.8.4987","article-title":"A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release","volume":"172","author":"Elssner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0150","doi-asserted-by":"crossref","first-page":"30471","DOI":"10.1074\/jbc.M802185200","article-title":"The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner","volume":"283","author":"Tomasinsig","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1111\/ddg.12101","article-title":"Rosacea\u2014S1 guideline","volume":"11","author":"Reinholz","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jidsymp.2011.5","article-title":"The cutaneous vascular system in chronic skin inflammation","volume":"15","author":"Huggenberger","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"Suppl 3","key":"10.1016\/j.jdermsci.2014.09.002_bib0165","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S0151-9638(11)70087-4","article-title":"Epidemiology of rosacea: updated data","volume":"138","author":"Chosidow","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1600-0560.2006.00695.x","article-title":"Lymphangiogenesis and angiogenesis in non-phymatous rosacea","volume":"34","author":"Gomaa","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0175","first-page":"16","article-title":"Advances in understanding and managing rosacea: Part 1: Connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"The cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0185","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0190","doi-asserted-by":"crossref","first-page":"C1100","DOI":"10.1152\/ajpcell.00494.2003","article-title":"Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release","volume":"286","author":"Kahlenberg","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0195","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.jid.5700526","article-title":"Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes","volume":"127","author":"Inoue","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X(7) receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0205","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0210","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.jid.5700591","article-title":"Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes","volume":"127","author":"Pastore","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0215","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2004-06-2435","article-title":"Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage","volume":"105","author":"Hirakawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2005.10.009","article-title":"Videocapillaroscopic alterations in erythematotelangiectatic rosacea","volume":"54","author":"Rosina","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2014.09.002_bib0225","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.jid.5701043","article-title":"In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37","volume":"128","author":"Carretero","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181114002199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181114002199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T02:27:55Z","timestamp":1538188075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181114002199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0923181114002199"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.09.002","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: Possible implications for rosacea","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}